
Kinled Holding
Description
Kinled Holding is a private equity and venture capital firm with offices in Hong Kong, London, and New York, specializing in start-ups and growth companies that possess strong identifiable patented technology. The firm primarily targets investments in the healthcare and technology sectors, seeking out innovative companies with proprietary intellectual property and substantial market potential. Kinled's investment approach emphasizes a long-term commitment, often participating in multiple funding rounds to support their portfolio companies' development from early to later stages.
A notable example of their sustained investment is Oxford Nanopore Technologies, where Kinled has been a consistent investor across numerous funding rounds since 2011, underscoring their dedication to fostering the growth of companies with disruptive technologies. This long-term perspective enables them to cultivate strong relationships with management teams and contribute strategically to the companies' trajectories.
While precise typical check sizes can fluctuate based on the specific stage and capital requirements of a company, Kinled Holding generally participates in funding rounds ranging from several million to tens of millions of dollars. Public records indicate their involvement in a £100 million Series G round for Oxford Nanopore in 2018 and a $250 million Series D round for the same company in 2020. Their focus on patented deep tech and life sciences ventures often necessitates significant capital for research, development, and eventual commercialization.
Kinled Holding's core investment philosophy revolves around identifying companies with robust technology platforms capable of achieving global scale. Their portfolio demonstrates a clear preference for enterprises poised for significant market disruption and possessing a well-defined path to commercial success. The firm's strategic global presence across key financial centers allows them to effectively source deals and provide comprehensive support to their international portfolio.
Investor Profile
Kinled Holding has backed more than 109 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 4% of its total and boasts 14 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Seed, Series A, Series Unknown rounds (top funding stages).
- Majority of deals are located in United Kingdom, United States, Switzerland.
- Strong thematic focus on Health Care, Biotechnology, Software.
- Typical check size: $5M – $25M.
Stage Focus
- Seed (47%)
- Series A (22%)
- Series Unknown (21%)
- Series B (6%)
- Series C (2%)
- Series D (1%)
- Series E (1%)
Country Focus
- United Kingdom (28%)
- United States (17%)
- Switzerland (17%)
- Germany (10%)
- Austria (6%)
- France (5%)
- Spain (3%)
- The Netherlands (2%)
- Singapore (1%)
- Canada (1%)
Industry Focus
- Health Care
- Biotechnology
- Software
- Financial Services
- Fintech
- Medical
- Medical Device
- Therapeutics
- Information Technology
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.